How to Remove Mycotoxins From the Body

Your body already has built-in systems for breaking down and clearing mycotoxins, centered on liver enzymes that chemically transform these fungal toxins into less harmful compounds that leave through urine and feces. The real question for most people is whether those systems are working well enough given the level of exposure, and what can be done to support or speed up the process. The answer involves a combination of stopping the source, helping the gut intercept toxins before they recirculate, and protecting cells from oxidative damage while the body does its work.

Your Body’s Built-In Clearance System

Before reaching for any supplement or protocol, it helps to understand what your liver and kidneys are already doing. When mycotoxins enter the body, they go through a two-phase detoxification process in the liver. In the first phase, a family of enzymes called cytochrome P450s chemically alters the mycotoxin molecule, sometimes making it more reactive in the process. In the second phase, other enzymes attach molecules like glutathione to the toxin, making it water-soluble enough to be excreted.

For aflatoxin B1, one of the most studied mycotoxins, specific liver enzymes convert it into a highly reactive intermediate. That intermediate then gets neutralized by glutathione-related enzymes, which are critical for safe disposal. Without adequate glutathione conjugation, the reactive intermediate can bind to DNA and proteins, which is exactly how aflatoxin causes liver damage over time.¹ Additional enzymes like epoxide hydrolase and aflatoxin-aldehyde reductase also contribute to clearing aflatoxin metabolites in humans.

Once the liver processes a mycotoxin, the breakdown products leave the body through two main routes. Animal studies with the trichothecene T-2 toxin show that about 75% of the toxin and its metabolites were excreted within five days, mostly through urine (roughly four parts urine to one part feces). The liver also dumps metabolites into bile, which carries them into the intestine for elimination.² This bile route matters because, as we’ll see, some mycotoxins get reabsorbed from the intestine back into the bloodstream rather than leaving the body, creating a cycle that prolongs exposure.

Stopping the Source Comes First

No clearance strategy works well if you are still being exposed. This sounds obvious, but it is the single most impactful step, and the one most often underweighted by people focused on supplements and protocols. Mycotoxin exposure happens through two major channels: contaminated food and water-damaged indoor environments. For people with illness linked to mold exposure, removing the person from the contaminated environment or remediating the building is considered the foundational step before any treatment begins.³

On the food side, the mycotoxins most commonly encountered in the diet include aflatoxins (from peanuts, corn, tree nuts), ochratoxin A (from coffee, wine, dried fruits, cereals), and deoxynivalenol or DON (from wheat and other grains). Food processing can substantially lower levels. Sorting and removing visibly damaged grains and nuts is surprisingly effective. Milling, soaking, and high-temperature processes like extrusion and roasting can further reduce contamination, and alkaline or acidic conditions during processing help chemically transform mycotoxins into less toxic forms.⁴ For practical purposes, this means buying from sources with good quality control, storing grains and nuts in dry conditions, and being cautious with foods known to carry higher contamination risk.

Binders That Intercept Mycotoxins in the Gut

One of the most direct strategies for speeding up mycotoxin removal involves binding agents, sometimes called enterosorbents, that physically grab mycotoxin molecules in the digestive tract and prevent them from being absorbed or reabsorbed. This approach targets a real vulnerability: certain mycotoxins like ochratoxin A undergo enterohepatic circulation, meaning the liver dumps them into bile, they reach the intestine, and then they get reabsorbed into the bloodstream instead of leaving the body. Breaking that cycle makes a meaningful difference.

Activated charcoal is the broadest-spectrum binder in the research. In laboratory testing simulating stomach conditions, activated charcoal bound all eight mycotoxins tested with high efficiency, outperforming every other sorbent. It also held onto most of those mycotoxins when conditions shifted to intestinal pH, though the bond with deoxynivalenol was less stable, with about 59% of that toxin released at intestinal pH.⁵ A practical downside of activated charcoal is that it binds indiscriminately. It can also grab medications, vitamins, and minerals, so timing matters if you use it.

Bentonite clay, a natural aluminosilicate mineral, is another well-studied option. Its layered structure and surface charge allow it to adsorb certain mycotoxins through electrostatic interactions and physical trapping in its interlayer spaces.⁶ Standard bentonite works well against aflatoxins but is less effective against ochratoxin A and some other mycotoxins. Chemically modified versions of bentonite, treated with hydrophobic compounds, show improved binding for ochratoxin A at both stomach and intestinal pH levels compared to the unmodified clay.⁷

For ochratoxin A specifically, cholestyramine is a prescription bile acid sequestrant that has shown particular promise. In animal studies, adding cholestyramine to the diet reduced blood levels of ochratoxin A and prevented kidney damage from the toxin.⁸ It works partly by binding the mycotoxin directly in the gut, but it also disrupts the enterohepatic recirculation that keeps ochratoxin A cycling through the body. Studies in mice confirmed that cholestyramine eliminates the cyclical pattern of ochratoxin A excretion that indicates reabsorption from the gut.⁹ Cholestyramine requires a prescription and is not without side effects, including constipation and interference with nutrient absorption, but for confirmed ochratoxin A exposure it is one of the better-supported pharmaceutical options.

An important caveat across all binders: most of the research uses animal models or laboratory simulations, not human clinical trials. The general principles are well established, and binders are widely used in veterinary medicine and food safety, but human dosing, timing, and effectiveness data remain limited. No binder besides activated charcoal could bind all eight tested mycotoxins simultaneously in the laboratory study described above, so matching the binder to the suspected toxin matters.

Protecting Cells With Antioxidant Support

While binders work in the gut to reduce the toxin load, a separate line of defense operates inside cells. Many mycotoxins cause damage through oxidative stress, generating reactive oxygen species that overwhelm the cell’s protective systems. Glutathione, the body’s most important intracellular antioxidant, plays a central role in neutralizing both the toxins themselves and the oxidative damage they cause. When mycotoxin exposure depletes glutathione, the resulting imbalance leads to tissue injury and systemic illness.¹⁰

N-acetylcysteine (NAC), a supplement available over the counter in most countries, is the most commonly discussed glutathione precursor. In cell studies, NAC pretreatment reduced the oxidative damage and blocked the programmed cell death triggered by the mycotoxin zearalenone.¹¹ In yeast models studying ochratoxin A, NAC both promoted glutathione accumulation and showed antioxidant properties that helped prevent lipid damage in cell membranes.¹² These are laboratory and cell-culture findings, not human clinical trials, but the biological logic is straightforward: if mycotoxins deplete glutathione, supplying a precursor to rebuild it should help cells cope.

Sulforaphane, a compound found at high levels in broccoli sprouts, works by a different mechanism. It activates a master regulatory switch called Nrf2, which turns on a whole battery of protective genes involved in both antioxidant defense and detoxification. Compared with other commonly used plant-derived supplements like curcumin, silymarin, and resveratrol, sulforaphane is a more potent activator of this Nrf2 pathway.¹³ The second-phase liver enzymes that safely neutralize aflatoxin are themselves regulated by Nrf2, so boosting this pathway may enhance the liver’s capacity to handle mycotoxins.¹⁴

Chlorophyllin as a Dietary Shield

One of the strongest pieces of human evidence for reducing mycotoxin damage comes from clinical trials of chlorophyllin, a water-soluble derivative of chlorophyll. In a randomized, placebo-controlled trial conducted in a region of China with high dietary aflatoxin exposure, taking chlorophyllin three times a day with meals led to a 55% reduction in a urinary biomarker of aflatoxin-DNA damage.¹⁵ That biomarker, aflatoxin-N7-guanine, is produced when aflatoxin’s most dangerous metabolite reacts with DNA, and higher levels are linked to increased liver cancer risk in long-term studies.

Chlorophyllin works not by speeding up excretion but by forming complexes with aflatoxin in the gut before it can be absorbed. It essentially acts as a molecular interceptor at the point of entry. A follow-up analysis confirmed roughly a 50% reduction in this DNA damage marker, with excellent compliance rates and no observed toxicity.¹⁶ The researchers noted that eating chlorophyll-rich foods (dark leafy greens) could offer a similar, more accessible benefit for people in areas with unavoidable aflatoxin exposure. This remains one of the few mycotoxin interventions tested in actual humans with meaningful clinical endpoints.

What Gut Bacteria Contribute

The gut microbiome turns out to be more than a bystander in mycotoxin exposure. Certain intestinal bacteria can enzymatically break down mycotoxins into less toxic metabolites, and some physically bind toxins to their cell walls, preventing absorption. This natural capacity has led researchers to investigate specific probiotic strains as potential mycotoxin countermeasures.¹⁷ The relationship runs both directions, though: mycotoxins can also disrupt the gut microbial community, shifting its composition in ways that may reduce its own detoxification capacity.

Beneficial gut microbes degrade or sequester mycotoxins, converting them into compounds with reduced or negligible toxicity.¹⁸ Much of this research has been developed in the context of animal agriculture, where probiotic and enzyme-based mycotoxin detoxifiers are already commercially available for livestock feed. Translating these findings to human use is still early-stage, but maintaining a diverse, healthy gut microbiome through dietary fiber and fermented foods is a reasonable supportive strategy with no downside.

Why Some People Clear Mycotoxins Poorly

Not everyone responds to mycotoxin exposure the same way, and genetics plays a real role in that variability. Certain variations in human leukocyte antigen (HLA) genes, specifically HLA-DR and HLA-DQ types, are associated with a reduced immune response to mycotoxins. People carrying these particular alleles appear to be poor eliminators who may develop symptoms of chronic exposure even from relatively modest or short-term contact with mold environments.¹⁹

This genetic angle helps explain why two people living in the same water-damaged building can have very different health outcomes. One person’s immune system may recognize and respond to mycotoxin exposure promptly, while another’s may fail to mount an adequate response, allowing the toxins to linger and accumulate. If you suspect you are unusually sensitive to mold, this is a line of investigation worth discussing with a physician, though HLA typing for mycotoxin susceptibility is still a relatively niche area of clinical practice.

Beyond HLA genes, individual variation in the glutathione-related enzymes that detoxify aflatoxin also matters. Polymorphisms in the GST enzyme family affect how quickly a person conjugates and excretes reactive aflatoxin intermediates.¹ Someone with less-active versions of these enzymes may be at higher risk for DNA damage and downstream health effects from the same level of dietary aflatoxin exposure.

How Different Mycotoxins Cause Damage

Understanding the kind of damage matters because different toxins call for different priorities in the clearance strategy. Trichothecene mycotoxins, the class that includes deoxynivalenol (DON) and T-2 toxin, work by binding to the ribosome, the cellular machinery that builds proteins. This triggers what researchers call a ribotoxic stress response, activating stress-signaling pathways that can lead to inflammation and programmed cell death.²⁰ In immune cells, this response drives both inflammatory cytokine production and cell death, which is why trichothecene exposure often shows up as immune system disruption.²¹

Ochratoxin A, by contrast, targets the kidneys particularly hard. It causes damage through multiple pathways including oxidative stress, disrupted autophagy, and interference with membrane transport systems.²² Animal studies show that DNA damage from ochratoxin A is more severe in kidneys than in the liver, underscoring why kidney protection matters in ochratoxin exposure.²³ For someone dealing with ochratoxin A, the combination of a binder like cholestyramine (to break the gut recirculation cycle) plus antioxidant support (to protect kidney cells) is a more targeted approach than a generic detox protocol.

The Problem With Mycotoxin Testing

Before you can decide what to remove, you need to know what you are dealing with, and this is where things get frustrating. Urinary mycotoxin testing is widely marketed to patients concerned about mold exposure, but the clinical validity of these tests is far from settled. A review of the evidence found that while many mycotoxin detection methods have been shown to accurately measure toxin concentrations under controlled laboratory conditions, they have not been adequately demonstrated to predict health status or guide clinical decisions in real patients.²⁴

The gap between “this test can detect mycotoxin in a urine sample” and “this test result tells you something actionable about your health” is larger than most testing companies acknowledge. Low levels of certain mycotoxins in urine are common in the general population simply because these compounds are widespread in the food supply. A positive result does not automatically mean you have a clinically significant burden, and it does not tell you whether the exposure is ongoing or residual. If a practitioner recommends mycotoxin testing, it is worth asking specifically how the results will change the treatment plan. In many cases, the practical steps (reduce exposure, support detoxification pathways, use appropriate binders) are the same regardless of what a urine panel shows.

Sweating and Sauna Claims

Infrared sauna sessions are frequently recommended in mold illness communities as a way to “sweat out” mycotoxins. The evidence for this specific claim is thin. A pilot study did detect organophosphate and pyrethroid pesticide metabolites in human sweat collected during infrared sauna use, and urinary concentrations of several pesticide metabolites marginally increased afterward.²⁵ But pesticide metabolites are not mycotoxins. They have different chemical properties, different distribution in the body, and different elimination pathways. Extrapolating from one class of environmental contaminant to another is a stretch that the published data does not support.

That said, sauna use is generally safe for most people and may offer indirect benefits: improved circulation, reduced inflammation markers, and stress reduction. If it makes you feel better, there is little reason to avoid it. Just don’t expect it to meaningfully move the needle on mycotoxin body burden compared to the approaches with stronger evidence, like binders and antioxidant support. The liver and kidneys are doing the heavy lifting here, and strategies that support those organs are more likely to matter than ones focused on the skin.

Putting a Practical Approach Together

Given the state of the evidence, a reasonable approach for someone concerned about mycotoxin exposure would layer several strategies by priority. First, identify and eliminate the source, whether that means remediating a water-damaged home, changing dietary patterns, or both.³ Second, consider a binding agent matched to the suspected toxin: activated charcoal for broad coverage, bentonite clay if aflatoxins are the concern, cholestyramine under medical supervision for ochratoxin A. Third, support your body’s own detox machinery with glutathione precursors like NAC, cruciferous vegetables or sulforaphane for Nrf2 activation, and chlorophyll-rich foods. Fourth, maintain a healthy and diverse gut microbiome through fiber and fermented foods.

A few cautions are worth noting. Activated charcoal and clay binders should be taken away from food, medications, and other supplements, as they bind indiscriminately. Cholestyramine is a prescription medication with real side effects and should not be taken without physician oversight. NAC is generally well tolerated, but high doses can cause gastrointestinal discomfort. And anyone pursuing a mycotoxin removal protocol should be realistic about timelines. Even in animal models with relatively clean elimination pathways, clearing most of a single-dose exposure took days. Chronic, ongoing exposure involves much longer accumulation in tissues, and the research on how long human clearance takes under various conditions is still sparse. Patience and sustained effort on multiple fronts will likely serve better than any single dramatic intervention.